Spotlight Therapeutics Venture Capital and Private Equity Financings

Spotlight Therapeutics ... Established in mid-2018, Spotlight Therapeutics is a privately held biotechnology company advancing a pipeline of cell-targeted in vivo ...

PR - Series B — Spotlight Therapeutics

Spotlight Therapeutics raises $36.5 million Series B to advance a pipeline of cell-targeted in vivo CRISPR gene editing biologics.

Spotlight Therapeutics - Valuation, Funding & Investors - PitchBook

Emerson Collective, EPIQ Capital Group, GordonMD Global Investments, Magnetic Ventures, and Team Builder Ventures are 5 of 8 investors who have invested in ...

Spotlight Therapeutics - Raised $80.7M Funding from 7 investors

Spotlight Therapeutics has raised a total funding of $80.7M over 4 rounds from 7 investors. Investors include Google Ventures, Emerson Collective and 5 ...

Spotlight Therapeutics Raises $36.5M in Series B Funding

USA – Spotlight Therapeutics, Inc., a Hayward, California-based biotechnology company applying new insights to develop cell-targeted in vivo ...

Spotlight Therapeutics Closes $30 Million Series A to Advance ...

Venture capital investment firm GV, formerly Google Ventures, led the Series A financing round for the company. Other investors contributed ...

Spotlight Therapeutics company information, funding & investors

Spotlight Therapeutics ; Dec 2020, N/A. $0.0. round ; Mar 2022 *. Emerson Collective · EPIQ Capital Group · Magnetic Ventures · GordonMD Global Investment. $36.5m.

Spotlight Therapeutics - Crunchbase Company Profile & Funding

Spotlight Therapeutics closed its last funding round on Mar 22, 2022 from a Series B round. Who are Spotlight Therapeutics 's competitors? Alternatives and ...

Spotlight Therapeutics - CB Insights

Spotlight Therapeutics is a biotechnology company focused on developing a new class of therapeutics through direct in vivo gene editing. The company's main ...

Spotlight Therapeutics Raises $36.5 Million Series B

Spotlight Therapeutics, Inc. (“Spotlight”), a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologics, ...

Spotlight Therapeutics company information, funding & investors

Spotlight Therapeutics ; Mar 2022 *. Emerson Collective · EPIQ Capital Group · Magnetic Ventures · GordonMD Global Investment. $36.5m. Series B ; Total Funding, € ...

Spotlight+Therapeutics Venture Capital and Private Equity Financings

VC News Daily provides funding details on Venture Capital backed startups ... Your Source for Venture Capital and Private Equity Financings. VC-funded ...

Spotlight Therapeutics - Company Profile - Tracxn

Spotlight Therapeutics - Developer of cancer therapeutics using gene editing. Raised a total funding of $80.7M over 4 rounds from 7 ...

Spotlight Therapeutics Closes $30M Series A Led by GV to Advance ...

SAN FRANCISCO--(BUSINESS WIRE)--Spotlight Therapeutics, Inc., a biotechnology company developing non-viral gene editing therapeutics for ...

Spotlight Therapeutics Stock Price, Funding, Valuation ... - CB Insights

Spotlight Therapeutics has raised $65.86M over 4 rounds. Spotlight Therapeutics's latest funding round was a Series B for $36.5M on January 5, 2022.

Spotlight Therapeutics - Gaebler.com Venture Capital Database

Wondering who provided funding to Spotlight Therapeutics? GV, GordonMD Global Investments and Epiq Capital joined the equity holders in this ...

Spotlight Therapeutics company information, funding & investors

Biotechnology company that develops biologics targeted to specific cell populations in gene editing. ... $146—219m (Dealroom.co estimates Mar 2022.) Hayward ...

Spotlight Therapeutics

Investors · Science. News. Press Releases · In the news · Presentations and posters ... Spotlight therapeutics. In vivo gene editing. Illuminating life-changing ...

Spotlight Therapeutics Funding Round - Gaebler Ventures

Epiq Capital, GordonMD Global Investments and Emerson Collective participated in a $36.5 million Series B funding round for Spotlight ...

Spotlight Medical Secures €6.2M in Seed Funding to Enhance ...

“This investment will accelerate our mission to harness the power of AI in analyzing patient data, providing physicians with the insights they ...